Does RIBOFLAVIN Cause Maternal exposure timing unspecified? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Maternal exposure timing unspecified have been filed in association with RIBOFLAVIN. This represents 0.8% of all adverse event reports for RIBOFLAVIN.
7
Reports of Maternal exposure timing unspecified with RIBOFLAVIN
0.8%
of all RIBOFLAVIN reports
7
Deaths
7
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From RIBOFLAVIN?
Of the 7 reports, 7 (100.0%) resulted in death, 7 (100.0%) required hospitalization, and 7 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN Cause?
Off label use (410)
Drug ineffective (372)
Nausea (271)
Drug hypersensitivity (270)
Product use in unapproved indication (265)
Pain (264)
Infusion related reaction (225)
Swelling (223)
Sleep disorder (214)
Pericarditis (210)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which RIBOFLAVIN Alternatives Have Lower Maternal exposure timing unspecified Risk?
RIBOFLAVIN vs RIBOFLAVIN 5'-PHOSPHATE
RIBOFLAVIN vs RIBOFLAVIN 5^-PHOSPHATE
RIBOFLAVIN vs RIFABUTIN
RIBOFLAVIN vs RIFAMPICIN
RIBOFLAVIN vs RIFAMPIN